Abstract Details

Title Efficacy of Pregabalin Treatment in Patients with Partial-Onset Epilepsy: Pooled Analysis of Six Long-Term, Open-Label Clinical Trials

Topic Epilepsy

Presentation(s) (-)

Poster/Presentation
Number 106

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Carl W. Bazil, MD, PhD, FAAN (Columbia University)	Dr. Bazil has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medical Letter . Dr. Bazil has received publishing royalties from a publication relating to health care.
Teresa Leon, MD, PhD (Novo Nordisk)	Dr. Leon has received personal compensation for serving as an employee of Novo Nordisk A/S Copenhagen. Dr. Leon has stock in Novo Nordisk. Dr. Leon has stock in Pharma Mar.
	No disclosure on file
	No disclosure on file
Reina Benabou, MD, PhD	No disclosure on file

��ɫ��